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surgery so that endovascular treatment failure can be quickly
recognized and further therapy can be offered.
CONCLUSIONS
Aortic disease associated with Marfan syndrome is a
complex clinical problem, however, some Marfan patients
may benefit from endovascular management. All patients
require close lifetime follow-up at a center specializing in
aortic surgery, as the rate of primary and secondary treat-
ment failure is high and many will require subsequent
interventions, including open conversion. Careful consid-
eration and collaboration between surgical specialties is
important prior to endovascular intervention to ensure that
an open operative intervention is not delayed, precluded, or
further complicated by the planned procedure.
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Dr Eric D. Endean (Lexington, Ky). I would like to congrat-
ulate the group from the University of Florida for the courage of
presenting their results for this difficult problem. The patients
presented in this series clearly represent a group for which treat-
ment options are difficult at best. To re-emphasize, 14 of the 16
patients were ASA class IV or IV-E and all were deemed poor
candidates for open surgical intervention. Fifteen patients had
undergone between one and five previous open aortic opera-
tions, averaging almost two open aortic operations per patient.
Not unexpectedly, the results are sobering. Four patients died
within months of the endovascular procedure and the results in
50% were classified as “successful.” Six patients, or 38%, were
classified as primary treatment failures. All patients with treat-
ment failures required an open repair and half of them died.
Two patients were felt to have secondary failure, ie, successful
treatment of the target pathology, but proximal or distal aortic1) As mentioned in the manuscript, the diagnosis of Marfan
syndrome was based on clinical assessment and/or patient
report. One patient had his initial aortic procedure at age 76.
How confident are you that all of the patients in this series
actually had Marfan syndrome?
2) This report examines only patients undergoing endovascular
treatment for Marfan syndrome. Over the same time period,
do the authors have information regarding how many patients
were treated for Marfan syndrome with an open repair?
3) All patients were believed to be high risk for open repair, yet
almost half ultimately required open repair for failure of the
endovascular graft. Have the authors learned what patient
factors or situations are more likely to result in endovascular
failure?
4) Finally, and similar to the prior question, has this experience
resulted in a change in how the University of Florida group
approaches the care of patients with aortic pathology associ-
ated with Marfan syndrome?
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manuscript and to the Association for the privilege of discussing
this article.
Dr Alyson Lee Waterman. Thank you, Dr Endean. With
regard to your first question, the 76-year-old gentleman did pres-
ent with an infrarenal abdominal aortic aneurysm. This was his first
vascular presentation. He did have a history of lens subluxation and
came with a self-reported history of Marfan syndrome. Although
he seemed to have the body habitus of Marfan syndrome, enough
for the clinicians include this as part of his medical history, it is very
possible that he did not, in fact, have a diagnosis of Marfan
syndrome. That is one of the difficulties of Marfan syndrome;
much of the diagnosis is based on clinical features alone and not all
patients undergo genetic screening for the fibrillin mutation. It is
possible that some of these patients in this study do not in fact have
that diagnosis.
With regard to your second question, comparing our endo-
vascular outcomes to open outcomes in the same patient popula-
tion is one of the areas that we have thought about looking at in the
p
vuture. There are a lot of open procedures performed by our
ardiothoracic colleagues in the Marfan population, but we have
ot yet looked at those together.
In terms of what factors result in treatment failure, I do not
hink that we can clearly identify from this study, exactly which
actors result in treatment failure. I do think that the Marfan
opulation has a spectrum of disease. Some of these patients seem
o have a more mild form of disease, having one intervention, and
he remainder of their aorta does not degenerate. Some of these
atients, however, even after multiple open and/or endovascular
nterventions, still continue to have aortic degeneration and re-
uire further procedures.
In terms of a change in our management, I think that this
tudy is going to make us look more critically at which patients we
ffer endovascular repair to. I think that there still is a place for
ndovascular repair to be offered, but I think we have to examine
ery closely which patients are offered this therapy, and these
atients all need to be followed very closely for any further inter-
entions they might require.
